🎉   Please check out our new website over at books-etc.com.

Seller
Your price
£16.60
RRP: £21.95
Save £5.35 (24%)
Dispatched within 2-3 working days.

The Myeloma Survival Guide

Essential Advice for Patients and Their Loved Ones

By (author) Dave Visel, Jim Tamkin
Format: Paperback / softback
Publisher: Springer Publishing Co Inc, New York, United States
Published: 30th Jul 2017
Dimensions: w 152mm h 229mm d 20mm
Weight: 480g
ISBN-10: 0826127053
ISBN-13: 9780826127051
Barcode No: 9780826127051
Trade or Institutional customer? Contact us about large order quotes.
Synopsis
The definitive guide to living a longer, fuller life with myeloma The Myeloma Survival Guide makes sense of the difficult questions myeloma patients face, dealing with every aspect of life after diagnosis, from creating a wellness team to navigating treatment options to building a financial safety net. Jim Tamkin, MD, who lived with myeloma for 11 years, and Dave Visel share the insights they've gained as a doctor, patient, and caregiver, including: Everything you need to know about drugs and treatments, including stem cell transplants How to deal with the pain and side effects of chemotherapy, radiation, and surgery Insurance and tax benefits to save money and get you the care you deserve Take-charge tools you can use today to feel better tomorrow The second edition has been thoroughly updated and includes a new chapter on pills and medical adherence.

New & Used

Seller Information Condition Price
-New£16.60
+ FREE UK P & P

What Reviewers Are Saying

Submit your review
Newspapers & Magazines
An invaluable guide to patients with newly diagnosed multiple myeloma. Not only have they provided clear information on the disease and its treatment, but most importantly also convey critical guidance on how to deal with the very personal life-impacting effects of this disease for patients and family members alike."" - Kenneth C. Anderson, MD, Kraft Family Professor of Medicine, Harvard Medical School, and Director, Jerome Lipper Multiple Myeloma Center and LeBow Institute for Myeloma Therapeutics, Dana-Farber Cancer Institute